SRPT SAREPTA THERAPEUTICS INC

Ownership history in BRAIDWELL LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in SAREPTA THERAPEUTICS INC (SRPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.32% (2024 Q4)
Avg. % of fund
0.77%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 832,100 +597,600 +254.8% 0.48% $16.0M $19.27
2025 Q1 REDUCED 234,500 -130,400 -35.7% 0.53% $15.0M $63.82
2024 Q4 REDUCED 364,900 -5,500 -1.5% 1.32% $44.4M $121.59
2024 Q3 ADDED 370,400 +288,500 +352.3% 1.31% $46.3M $124.89
2024 Q2 REDUCED 81,900 -58,452 -41.6% 0.41% $12.9M $158.00
2022 Q4 INITIATED 140,352 0.61% $18.2M
% of Fund (quarterly)    SRPT price (monthly, adj. close)
← Back to BRAIDWELL LP Holdings